Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight within a six-to-twelve-month period, is a clinical challenge that often signals serious underlying pathology. A comprehensive, systematic approach is crucial in diagnosing the cause of UWL in patients.
The initial evaluation should include a detailed history and physical examination. Key elements to consider are the timeframe of weight loss, associated symptoms, medication history, psychosocial factors, and family history. Physical examination should focus on signs of malnutrition, malignancy, endocrine disorders, and chronic diseases.
Initial laboratory investigations should include complete blood count, comprehensive metabolic panel, thyroid function tests, HIV test, and urinalysis. The decision to proceed with further diagnostic imaging should be guided by the clinical suspicion raised from the history and physical examination.
If initial investigations are inconclusive, more specialized testing may be warranted. This could include endoscopic procedures, cardiac evaluation, or psychiatric assessment, depending on the suspected underlying cause.
Management should be tailored to the identified cause. If no cause is found after a comprehensive evaluation, the patient should be closely monitored with scheduled follow-ups. In some cases, UWL may be the first sign of a disease that will become clinically evident with time.
Unexplained weight loss is a complex clinical issue that requires a comprehensive and systematic approach for effective diagnosis. By thoroughly evaluating the patient's history, physical examination, and appropriate laboratory and imaging studies, healthcare professionals can identify potential causes and initiate appropriate management strategies. Continued vigilance in follow-up is crucial as UWL may be an early indication of a yet-to-be-diagnosed condition.
1.
Extracellular matrix pathway emerges as treatment target for pediatric cancer
2.
Researchers explore e-bikes for cancer recovery
3.
According to new studies, some cancer patients can safely forego radiation therapy.
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
A single bout of exercise gives results that could help cancer patients
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
Undersanding Alemtuzumab: What You Need To Know About This Multiple Sclerosis Medication
3.
Clonal Hematopoiesis and Healthy Aging: Insights, Mechanisms, and Clinical Relevance
4.
Clinical Guidance for Survivorship-Focused Cancer Care
5.
Bone Marrow Regenerative Capacity and Hematologic Recovery
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
Recognizing Symptoms of Vitamin B12 Deficiency
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation